CD2 and rheumatoid arthritis: Bioinformatics research revealed that LLDT-8 primarily regulates the systemic and specific immune-related pathways of RA-FLS or targets inhibition of the T-cell surface antigen CD2 to perform its potent anti-inflammatory and immunosuppressive function in RA (32, 33).